Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma (Q40409946)
Jump to navigation
Jump to search
scientific article published on August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma |
scientific article published on August 2005 |
Statements
1 reference
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma (English)
1 reference
Roman Rouzier
1 reference
George Blumenschein
1 reference
Gabriel N Hortobagyi
1 reference
Lajos Pusztai
1 reference
Peter Wagner
1 reference
Nuhad Ibrahim
1 reference
Edgardo Rivera
1 reference
Richard Theriault
1 reference
Daniel Booser
1 reference
Fraser W Symmans
1 reference
Franklin Wong
1 reference
Donald R Fleming
1 reference
Graeme Boniface
1 reference
1 August 2005
1 reference
1 reference
104
1 reference
4
1 reference
682-691
1 reference
Identifiers
1 reference
1 reference